
Overview
Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders. Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications.
Dr. Andreadis is highly rated in 33 conditions, according to our data. His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MEDICARE DISCOUNT CARD
- MEDICARE MAPD
Locations
400 Parnassus Ave., Fourth Floor, San Francisco, CA 94143
Additional Areas of Focus
Dr. Andreadis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Cutaneous Lymphoma Clinic
Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is highly rated in 28 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), T-Cell Lymphoma, Hodgkin Lymphoma, and Bone Marrow Aspiration.
Interstitial Lung Disease (ILD) Program
Dr. Steven Hays, a pulmonologist, is medical director of the UCSF Lung Transplant Program, which is known for accepting patients with complex conditions while maintaining superior survival rates. His expertise is in caring for patients with end-stage lung disease who proceed through the lung transplant process. He treats conditions that include cystic fibrosis, emphysema associated with alpha-1 antitrypsin deficiency, and interstitial lung disease. In research, Hays focuses on studying how airway remodeling occurs in the transplanted lung. Hays earned his medical degree at the University of Kansas. He completed a residency in internal medicine at the University of Kansas Medical Center, where he served as chief resident, followed by a fellowship in pulmonary and critical care medicine at UCSF. He also completed a lung transplant fellowship at Stanford Health Care. Dr. Hays is highly rated in 15 conditions, according to our data. His top areas of expertise are Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Endoscopy.
Office
Aijaz Ahmed is a Transplant Surgeon in Palo Alto, California. Dr. Ahmed is highly rated in 32 conditions, according to our data. His top areas of expertise are Hepatitis, Hepatitis C, Non-Alcoholic Fatty Liver Disease, Liver Transplant, and Hepatectomy.
Frequently Asked Questions about Dr. Charalambos (. Andreadis
How do I make an appointment with Dr. Charalambos (. Andreadis?
You can book an appointment with Dr. Charalambos (. Andreadis by calling their office at 415-353-2051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Charalambos (. Andreadis a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charalambos (. Andreadis is classified as an Distinguished expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Charalambos (. Andreadis specialize in?
While Dr. Charalambos (. Andreadis is a Hematology Oncology, they have specific expertise in Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Charalambos (. Andreadis accept my insurance?
Dr. Charalambos (. Andreadis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 415-353-2051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Lymphoblastic Leukemia (ALL)Dr. Andreadis isDistinguished. Learn about Acute Lymphoblastic Leukemia (ALL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Andreadis isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Andreadis isDistinguished. Learn about Follicular Lymphoma.
- Gastric LymphomaDr. Andreadis isDistinguished. Learn about Gastric Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Andreadis isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Andreadis isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Andreadis isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaDr. Andreadis isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Andreadis isAdvanced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaDr. Andreadis isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acute Monoblastic Leukemia (AmoL)Dr. Andreadis isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Andreadis isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult T-Cell LeukemiaDr. Andreadis isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Andreadis isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Andreadis isExperienced. Learn about Aplastic Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Andreadis isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).


